Status:
COMPLETED
Effect of Mediterranean-DASH Intervention for Neurodegenerative Delay Plus Forest Bathing
Lead Sponsor:
Hong Kong Metropolitan University
Conditions:
High Blood Pressure
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
This proposed study will be the first to investigate the effect of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Plus Forest Bathing (FB) on blood pressure (BP) and cognitive ...
Detailed Description
Research aim 1. This study will aim to investigate the effect of MIND and MIND plus FB on hypertension. 2. To examine the effect of MIND alone on hypertension by controlling other covariates. 3. To d...
Eligibility Criteria
Inclusion
- aged 60 and above;
- Chinese ethnicity;
- ability to speak and understand Chinese;
- fulfilment of the AHA criteria for stage 1 and stage 2 hypertension; and
- who could walk independently
Exclusion
- have allergy to more than one type of food (nuts, berries, olive oil, or fish);
- participation in any dietary or relaxation programme within the past 3 months
Key Trial Info
Start Date :
January 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05342896
Start Date
January 3 2021
End Date
March 31 2023
Last Update
November 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Queenie Law
Hong Kong, Hong Kong